Just released. Phase III trial hits clinical trial endpoints with no safety issues. Stock up strong AH 11-11.50... Based on this board I must be the only person in the US who owns it so congrats to me! In from the low 9's...LOL!
Good and Perhaps Overbought short-term. This was a confirmatory phase 3 trial. They hit stat sig results in the Fall of 2009 on a phase 3 before they even went public. However, what;s important is that the FDA loves confirmatory trials. I think if there are no safety issues, this is a shoe-in and perhaps a big market. I have this intermittant diarrhea-constipation problem myself and I'm looking for something to help me.